- Home
- INSE vs DRUG Comparison
INSE vs DRUG Comparison
Compare INSE & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- DRUG
- Stock Information
- Founded
- INSE 2002
- DRUG 2019
- Country
- INSE United States
- DRUG United States
- Employees
- INSE N/A
- DRUG N/A
- Industry
- INSE Computer Software: Prepackaged Software
- DRUG Pharmaceuticals and Biotechnology
- Sector
- INSE Technology
- DRUG Health Care
- Exchange
- INSE Nasdaq
- DRUG Nasdaq
- Market Cap
- INSE 234.9M
- DRUG 199.7M
- IPO Year
- INSE N/A
- DRUG N/A
- Fundamental
- Price
- INSE $9.21
- DRUG $33.75
- Analyst Decision
- INSE Buy
- DRUG Strong Buy
- Analyst Count
- INSE 6
- DRUG 7
- Target Price
- INSE $13.50
- DRUG $83.25
- AVG Volume (30 Days)
- INSE 185.1K
- DRUG 38.7K
- Earning Date
- INSE 08-06-2025
- DRUG 08-13-2025
- Dividend Yield
- INSE N/A
- DRUG N/A
- EPS Growth
- INSE 3507.71
- DRUG N/A
- EPS
- INSE 2.43
- DRUG N/A
- Revenue
- INSE $295,200,000.00
- DRUG N/A
- Revenue This Year
- INSE $2.43
- DRUG N/A
- Revenue Next Year
- INSE $3.19
- DRUG N/A
- P/E Ratio
- INSE $3.86
- DRUG N/A
- Revenue Growth
- INSE N/A
- DRUG N/A
- 52 Week Low
- INSE $6.51
- DRUG $0.94
- 52 Week High
- INSE $11.61
- DRUG $79.02
- Technical
- Relative Strength Index (RSI)
- INSE 59.68
- DRUG 64.98
- Support Level
- INSE $9.07
- DRUG $32.73
- Resistance Level
- INSE $9.57
- DRUG $37.59
- Average True Range (ATR)
- INSE 0.31
- DRUG 2.24
- MACD
- INSE -0.03
- DRUG 1.05
- Stochastic Oscillator
- INSE 51.30
- DRUG 71.74
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.